Relief for men experiencing the challenges of Benign Prostatic Hyperplasia (BPH), or prostate enlargement, has arrived with the introduction of Flowel and Flowel Plus by Superior Pharmaceuticals ...

Study shows boosting diet with supplements could halt prostate tumour growth and help men avoid unnecessary surgery, chemo or ...

The U.S. Food and Drug Administration (FDA) has granted fast track designation to Alessa Therapeutics for its lead product ...

Akeega combines niraparib, a PARP inhibitor, and abiraterone acetate, a CYP17 inhibitor, into a single tablet for BRCA2-mutated mCSPC.

A growing array of pharmaceutical options has investigators trying to figure out which drugs and drug combinations are the best to prescribe upfront—and to which patients. Over the past 14 years, ...

Researchers at Case Western Reserve University have developed a treatment for advanced prostate cancer that could eliminate a ...

A new way to prevent excruciating pain from the side effects of advanced prostate cancer therapy has been developed.Many men ...

A new long-term prediction tool estimates the risk of dying from prostate cancer, offering a more accurate way to interpret ...

A new study published in Nature Communications provides a framework for researching whether earlier, model-guided treatment ...